Author： Tobón Gabriel J Saraux Alain Pers Jacques-Olivier Youinou Pierre
Publisher： Informa Healthcare
ISSN： 1472-8214
Source： Expert Opinion on Emerging Drugs, Vol.15, Iss.2, 2010-06, pp. : 269-282
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Emerging biotherapies for inflammatory bowel disease
Expert Opinion on Emerging Drugs, Vol. 8, Iss. 2, 2003-11 ,pp. :
Access to resources
Recommend
By Amarasena Roshan Bowman Simon
Clinical Medicine, Vol. 7, Iss. 1, 2007-01 ,pp. :
Targeting IL-1 in Sjögren's syndrome
By Yamada Akiko Arakaki Rieko Kudo Yasusei Ishimaru Naozumi
Expert Opinion on Therapeutic Targets, Vol. 17, Iss. 4, 2013-04 ,pp. :
Biologic Therapies in Primary Sjogren's Syndrome
Current Pharmaceutical Biotechnology, Vol. 13, Iss. 10, 2012-08 ,pp. :